Trial NCT03515629

View at ClinicalTrials.gov 
Org. Study IDs: R2810-ONC-16111
Secondary IDs: 2017-001041-27

Last trial update was posted on 2022-11-16

MeSH Interventions

Cemiplimab Pembrolizumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer

Stopping Reasons

Business decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID